Clinical Trials Logo
  1. Home
  2. Adverse Effects
  3. NCT01650272

Efficacy and Safety Comparing 5% Monoxidil Milky Lotion Versus 5% Minoxidil Solution in Androgenetic Alopecia

Adverse Effects Clinical Trial

Official title:
An Efficacy and Safety Pilot Study Comparing 5% Monoxidil Milky Lotion Versus 5% Minoxidil Solution in Treatment of AGA

Clinical Trial Summary

5% Minoxidil lotion was approved for using to stimulate hair growth in male androgenetic alopecia by US FDA science 1988. The mechanism of action still unclear. In general the 5% Minoxidil in solution is the first choice preparation for treatment, therefore allergic contact dermatitis to solution was report up to 5.7% (Ebner H. et al,1995). Propylene glycol which is the main solvent of these solution, was the main responsible to allergic contact dermatitis with positive patch test up to 81.8% (Friedman ES. et al. 2002) One of the alternative solution using butylene glycol as the solvent was invented to solve the problem. In Siriraj hospital the investigators using this new solvent and made our in house product called 5% Minoxidil milky lotion. However the efficacy and safety of the new solution have not been investigated. This study is conducted to evaluated efficacy and safety of 5% Minoxidil milky lotion compare with the classic solution in male androgenetic alopecia.

Clinical Trial Description

The 5% Minoxidil in solution is the first choice preparation for treatment for Androgenetic Alopecia (AGA), 5% Minoxidil milky lotion is the alternative solution using butylene glycol as the solvent to solve allergic contact dermatitis problem. In Siriraj hospital the investigators using this new solvent and made our in house product called he efficacy and safety of the new solution have not been investigated. This study is conducted to evaluated efficacy and safety of 5% Minoxidil milky lotion compare with the classic solution in male androgenetic alopecia. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01650272
Study type Interventional
Source Siriraj Hospital
Contact Rattapon Thuangtong, MD
Phone +662 4194333
Email rattaponthuangtong@yahoo.com
Status Recruiting
Phase Phase 1/Phase 2
Start date June 2012
Completion date April 2013
View Details
See also
  Status Clinical Trial Phase
Completed NCT01764126 - Pneumococcal Protein Vaccine Safety and Immunogenicity Trial Phase 1
Completed NCT00696839 - Trial of Cognitive Behavioral Therapy to Reduce Antiretroviral Therapy Side Effects N/A
Completed NCT00361062 - Aggressive Behavior Induced by Selective Serotonin Reuptake Inhibitors (SSRIs) During the First Month of Treatment N/A
Completed NCT00346944 - Health Effects From Removal of Amalgam Restorations in Patients With Symptoms Allegedly Related to Dental Amalgam Phase 4
Recruiting NCT05486923 - Validity and Reliability Evaluation of the PRO-CTCAE for Adult-type Diffuse Gliomas Patients in Chinese Population
Completed NCT01834898 - Safety and Tolerability of Controlled-release Oxycodone on Postoperative Pain in Oncologic Head and Neck Surgery N/A
Completed NCT01041352 - Laryngeal Mask or Endotracheal Tube for Back Surgery in the Prone Position N/A
Recruiting NCT05090384 - Pediatric GVHD Low Risk Steroid Taper Trial Phase 2
Completed NCT02927587 - Optimal TCI Regimen for Sedation of Elderly Undergoing Fiberoptic Bronchoscopy N/A
Completed NCT02162147 - How Safe Are Our Pediatric Emergency Departments? N/A
Completed NCT01471366 - Method of Fish Oil Administration on Patient Compliance N/A
Completed NCT00773942 - Design & Evaluation of a Medication Therapy Management Program to Improve Patient Safety in Medicare Beneficiaries N/A
Completed NCT06102577 - Systemic Adverse Effects After Osteopathic Treatment and Vitamin C N/A
Completed NCT01060410 - Exploration of Genotype Based Personalized Prescription of Cyclophosphamide in Systemic Lupus Erythematosus Treatment N/A
Active, not recruiting NCT00445016 - Neurologic Complications in Peripheral Regional Anesthesia - An Evaluation Based on a Standardized Protocol N/A
Active, not recruiting NCT02668016 - Self-Assessment Method for Statin Side-effects Or Nocebo Phase 4
Completed NCT01533792 - Effect of Non-surgical Periodontal Treatment Phase 2
Active, not recruiting NCT05032976 - Korea Comirnaty Post-marketing Surveillance
Completed NCT01116323 - Emergency Department Crowding in Relation to In-hospital Adverse Medical Events
Completed NCT02159911 - Oral Misoprostol for Cervical Priming Before Hysteroscopy N/A